Home › Research › How common it is
Cognitive and Renal Outcomes of Finerenone in Older Adults With Heart Failure With Preserved Ejection Fraction: A Real-World Cohort Study
Al-Nusair M, Haddad TA, Khurana S, Al-Nusair J.. Research Square, 2026-10-06
Topic: Drug trials: efficacy and safety
Plain-language summary
Background Heart failure with preserved ejection fraction (HFpEF) disproportionately affects older adults, in whom dementia and cognitive decline are frequent but underrecognized. Steroidal mineralocorticoid receptor antagonists (MRAs) have been linked to lower dementia risk. Whether this extends to finerenone is unknown. Methods This retrospective TriNetX cohort study identified adults aged ≥ 65 with a first HFpEF diagnosis (July 9, 2021–September 14, 2026). The primary outcome was six-month incidence of dementia or cognitive decline; the secondary was a composite adverse renal outcome. Results Each matched cohort included 1,660 patients. Dementia or cognitive decline occurred in 1% of the finerenone group versus 1.4% of controls (HR 0.9, 95%CI 0.46─1.60). The composite renal outcome was significantly lower with finerenone (11.1% vs 20.3%; HR 0.6, 95%CI 0.47─0.67). Conclusion In older adults with HFpEF, finerenone conferred renal benefit without a detectable short-term cognitive signal. Longer follow-up with standardized cognitive assessment is needed before excluding neuroprotection.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Al-Nusair, M., Haddad, T. A., Khurana, S., & Al-Nusair, J. (2026). Cognitive and Renal Outcomes of Finerenone in Older Adults With Heart Failure With Preserved Ejection Fraction: A Real-World Cohort Study. Research Square. https://doi.org/10.21203/rs.3.rs-11263755/v1
Vancouver
Al-Nusair M, Haddad TA, Khurana S, Al-Nusair J. Cognitive and Renal Outcomes of Finerenone in Older Adults With Heart Failure With Preserved Ejection Fraction: A Real-World Cohort Study. Research Square. 2026. doi:10.21203/rs.3.rs-11263755/v1.
BibTeX
@article{alnusair2026-96e671cd,
author = {Al-Nusair, M. and Haddad, T. A. and Khurana, S. and Al-Nusair, J.},
title = {{Cognitive and Renal Outcomes of Finerenone in Older Adults With Heart Failure With Preserved Ejection Fraction: A Real-World Cohort Study}},
journal = {Research Square},
year = {2026},
doi = {10.21203/rs.3.rs-11263755/v1},
url = {https://doi.org/10.21203/rs.3.rs-11263755/v1}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Results Each matched cohort included 1,660 patients.
- Dementia or cognitive decline occurred in 1% of the finerenone group versus 1.4% of controls (HR 0.9, 95%CI 0.46─1.60).
- The composite renal outcome was significantly lower with finerenone (11.1% vs 20.3%; HR 0.6, 95%CI 0.47─0.67).
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Study designcohort study
- Participants1,660
- Effect size1.4%; HR 0.9; 11.1%
- Evidence strengthModerate
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 50 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 31 of the 62 points we could judge it on, which is 50 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (Research Square) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 3 / 4 | 1,660 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 31 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 31 of the 62 points we could judge it on is 50 out of 100. |
| Total | 50 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in How common it is from nearby years
Also tagged “cholinesterase”
272 studies in the library carry the topic tag “cholinesterase”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 272 tagged studies.